The battle against the obesity epidemic: Is bariatric surgery the perfect weapon?

Clinical and Investigative Medicine

Volumn 28, Issue 4, 2005, Pages 147-156

  Karmali, Shahzeer ^a   Shaffer, Eldon ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; TETRAHYDROLIPSTATIN;

BARIATRIC SURGERY; BEHAVIOR; BODY MASS; BREAST CANCER; CLINICAL TRIAL; COLON CANCER; COMORBIDITY; CONSERVATIVE TREATMENT; CORONARY ARTERY DISEASE; DEVELOPED COUNTRY; DIABETES MELLITUS; DIET THERAPY; ENERGY EXPENDITURE; EXERCISE; GALLSTONE FORMATION; GASTRIC BANDING; GASTROESOPHAGEAL REFLUX; GASTROPLASTY; HEALTH CARE COST; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LAPAROSCOPIC SURGERY; LOW CALORY DIET; META ANALYSIS; OBESITY; OSTEOARTHRITIS; PANCREATITIS; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SLEEP APNEA SYNDROME; STOMACH BYPASS; STROKE; SYSTEMATIC REVIEW; UNITED STATES; WEIGHT GAIN; WEIGHT REDUCTION;

BARIATRICS; BODY MASS INDEX; FEMALE; GASTRIC BYPASS; GASTROPLASTY; HUMANS; LAPAROSCOPY; MALE; OBESITY; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 23844446717     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. World Health Organization consultation on obesity. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: World Health Organization, Division of Noncommunicable Disease Programme of Nutrition Family and Reproductive Health; 1997.
2. Flegal, K. M., Carroll, M. D., Kuczmarski, R. J. et al. Overweight and Obesity in the United States: Prevalence and Trends, 1960-1994. Int. J Obes Relat Metab Disord 1998;22:39-47.
3. Ogden, C. L., Flegal, K. M., Carroll, M. D., et al. Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000. JAMA 10-9-2002; 288:1728-32.
4. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: The Organization; 2004. Report No.: Technical report series 894.
5. Mokdad, A. H., Serdula, M. K., Dietz, W. H., et al. The Spread of the Obesity Epidemic in the United States, 1991-1998. JAMA 11-27-1999;282:1519-22.
6. Statistics Canada. National population Health Survey. Ottawa; 1994. Report No.: 82-F0001XCB.
7. Birmingham CL, Muller JL, Palepu A et al. The Cost of Obesity in Canada. CMAJ 1999;16:483-8.
8. Stein CJ, Colditz GA. The Epidemic of Obesity. J Clinc Endocrinol Metab 2004;89:2522-5.
9. National Institutes of Health. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. Bethesda, MD; 1998.
10. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: The Organization; 2000. Report No.: Technical report series 894.
11. Westlund K, Nickolaysen R. Ten Year Mortality and Morbidity Related to Serum Cholesterol. A Follow Up of 3 751 Men Aged 40-49. Scan J Clin Lab Invest 1992;30:1-24.
12. Kannel WE, Kuo PT, Conn HL Jr, et al. Health and obesity: an overview Health and Obesity. 1983. pp.1-19.
13. Romero, Y., Cameron, A. J., Locke, G. R., et al. Familial Aggregation of Gastroesophageal Reflux in Patients With Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology 1997;113:1449-56.
14. Locke, G. R., III, Talley, N. J., Fett, S. L., et al. Risk Factors Associated With Symptoms of Gastroesophageal Reflux. Am. J Med. 1999;106:642-9.
15. Ruth, M., Mansson, I., Sandberg, N. The Prevalence of Symptoms Suggestive of Esophageal Disorders. Scand. J Gastroenterol. 1991;26:73-81.
16. Shaffer, E. A., Small, D. M. Gallstone Disease: Pathogenesis and Management. Curr. Probl. Surg 1976; 13:3-72.
17. Maclure, K. M., Hayes, K. C., Colditz, G. A., et al. Weight, Diet, and the Risk of Symptomatic Gallstones in Middle-Aged Women. N. Engl. J Med. 9-31-1989;321:563-9.
18. Garcia-Monson, C., Martin-Perez, E., Iacono, O. et al. Characterization of Pathogenic and Prognostic Factors of Nonalcoholic Steatohepatitis Associated With Obesity. J Hepatol 200;33:716-24.
19. Haynes, P., Liangpunsakul, S., Chalasani, N. Nonalcoholic Fatty Liver Disease in Individuals With Severe Obesity. Clinics in Liver Disease 2004;8:535-47.
20. Kolotkin, R.L., Meter, K., Williams, G.R. Quality of Life and Obesity. Obesity Reviews 2001;2:219-29.
21. Shaffer EA. Nonalcoholic Steoatohepatitis: More Than Just Being Fat. The Canadian Journal of Gastroenterology 2002;16:318-21.
22. Festi, E., Colecchia, A., Sacco, T. et al. Hepatic Steatosis in Obese Patients: Clinical Aspects and Prognostics Significance. Obesity Reviews 2004;5:27-42.
23. Malnick, S.D., Beergabel, M., Knobler, H. Non-Alcoholic Fatty Liver: a Common Manifestation of a Metabolic Disorder. QJM. 2003;96:699-709.
24. American Gastroenterological Association Clinical Practice Committee. AGA Technical Review on Obesity. Gastroenterology 2002;123:882-932.
25. Kline, S., Fontana, L., Young, V.L. et al. Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease. N Engl J Med 2004;350:249-57.
26. Carr, D.B., Ultzschneider, K.M., Hall, R.L. et al. Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Panel III Criteria for the Metabolic Syndrome. Diabetes Care 2004;53:2087-94.
27. Wadden, T. A., Foster, G. D., and Letizia, K. A. One-Year Behavioral Treatment of Obesity: Comparison of Moderate and Severe Caloric Restriction and the Effects of Weight Maintenance Therapy. J Consult Clin Psychol. 1994;62:165-71.
28. Wood, P.D., Stefanick, M.L., Dreon D.M., et al. Changes in Plasma Lipid and Lipoproteins in Overwight Med During Weight Loss Through Dieting As Compared With Exercise. N. Engl. J. Med. 1988;319:1173-9.
29. Wadden, T. A. and Foster, G. D. Behavioral Treatment of Obesity. Med. Clin North Am. 2000;84:441-61, vii.
30. Patterson, E. J., Urbach, D. R., and Swanstrom, L. L. A Comparison of Diet and Exercise Therapy Versus Laparoscopic Roux-En-Y Gastric Bypass Surgery for Morbid Obesity: a Decision Analysis Model. J Am Coll. Surg 2003;196:379-84.
31. Mitka, M. Surgery for Obesity: Demand Soars Amid Scientific, Ethical Questions. JAMA 2003;289:1761-3.
32. McMahon, F. G., Fujioka, K., Singh, B. N., et al. Efficacy and Safety of Sibutramine in Obese White and African American Patients With Hypertension: a 1-Year, Double-Blind, Place bo-Controlled, Multicenter Trial. Arch Intern. Med 7-24-2000;160:2185-91.
33. Bray GA. Drug Treatment of Obesity. Rev Endocr Metab Disord 2001;2:403-18.
34. Bray, G.A., Blackburn, G.L., Ferguson J.M., et al. Sibutramine Produces Dose-Related Weight Loss. Obes Res 1999;7:189-98.
35. Davidson, M.H., Hauptman, J., DiGirolamo, M., et al. Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat: a Randomized Controlled Trial. JAMA 1999;81:235-42.
36. Fisher, B. L. and Schauer, P. Medical and Surgical Options in the Treatment of Severe Obesity. Am J Surg 2002;184(6B):9S-16S.
37. Stocker, D. J. Management of the Bariatric Surgery Patient. Endocrinol. Metab Clin North Am. 2003;32:437-57.
38. Scott, H.W Jr., Law, D.H., Sandstead, H.H., et al. Jejunoileal Shunt in Surgical Treatment of Morbid Obesity. Ann Surg. 1970;May 171:770-82.
39. Mason, E. E. Vertical Banded Gastroplasty for Obesity. Arch Surg 1982;117:701-6.
40. Macgregor A. The Story of Surgery for obesity. American Society of Bariatric Surgery. 2002. Available: http://www.asbs.org/html/story/chapter1.html
41. Krai, J.G., Bray, G.H., Bouchard, C., et al. Surgical treatment of obesity. Handbook of Obesity. New York: Marcel Dekker; 1997. p.977.
42. Schweiz, B. A. From the Food and Drug Administration. JAMA 12-5-2001;286:2660.
43. Belachew, M., Legrand, M., Vincent, V, et al. Laparoscopic Adjustable Gastric Banding. World J Surg 1998;22:955-63.
44. DeMaria, E.J., Sugerman, H.J., Kellum J.M. High Failure Rate Following Laparoscopic Adjustable Silicone Gastric Banding for Treatment of Morbid Obesity. Ann Surg 2001 2001;233:809-18.
45. Pories, W. J., Swanson, M. S., MacDonald, K. G., et al. Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus. Ann Surg 1995;222:339-50.
46. MacLean, L. D., Rhode, B. M., Sampalis, J., et al. Results of the Surgical Treatment of Obesity. Am J Surg 1993;165:155-60.
47. Sugarman, J. R., Grossman, D. C. Trauma Among American Indians in an Urban County. Public Health Rep. 1996;111:321-7.
48. Hall, J. C., Watts, J. M., O'Brien, P. E., et al. Gastric Surgery for Morbid Obesity. The Adelaide Study. Ann Surg 1990;211:419-27.
49. Howard, L., Malone, M., Michalek, A., et al. Gastric Bypass and Vertical Banded Gastroplasty- a Prospective Randomized Comparison and 5-Year Follow-Up. Obes. Surg 1995;5:55-60.
50. Scopinaro, N., Adami, G.F., Marinari, G.M., et al. Biliopancreatic Diversion. World J Surg 1998;22:936-46.
51. Schauer, P., Ikramuddin, S., Hamad, G., et al. The Learning Curve for Laparoscopic Roux-En-Y Gastric Bypass Is 100 Cases. Surg Endosc. 2003;17:212-5.
52. Nguyen, N. T., Goldman, C., Rosenquist, C. J., et al. Laparoscopic Versus Open Gastric Bypass: a Randomized Study of Outcomes, Quality of Life, and Costs. Ann Surg 2001;234:279-89.
53. Schauer, P.R., Ikramuddin, S., Gourash, W., et al. Outcomes After Laparoscopic Roux-En-Y Gastric Bypass for Morbid Obesity. Ann Surg. 2000;232:515-29.
54. Colquitt, J., Clegg, A., Sidhu, M., et al. Surgery for Morbid Obesity. Cochrane Database Systematic Review 2003 2003;CD003641.
55. Higa Kelvin. Laparoscopic Surgery for Morbid Obesity. Cameron JL. Current Surgical therapy 8th edition. Philadelphia: Elsevier Mosby; 2004. pp.1292-4.
56. Buchwald, H., Avidor, Y., Braunwald, E., et al. Bariatric Surgery: a Systematic Review and Meta-Analysis. JAMA 10-13-2004;292:1724-37.
57. Charuzi, I., Ovnat, A., Peiser, J., et al. The Effect of Surgical Weight Reduction on Sleep Quality in Obesity-Related Sleep Apnea Syndrome. Surgery 1985;97:535-8.
58. Sugerman, H. J., Baron, P. L., Fairman, R. P., et al. Hemodynamic Dysfunction in Obesity Hypoventilation Syndrome and the Effects of Treatment With Surgically Induced Weight Loss. Ann Surg 1988;207:604-13.
59. Carson, J. L., Ruddy, M. E., Duff, A. E., et al. The Effect of Gastric Bypass Surgery on Hypertension in Morbidly Obese Patients. Arch Intern. Med. 2-24-1994;154:193-200.
60. Gleysteen, J. J., Barboriak, J. J. Improvement in Heart Disease Risk Factors After Gastric Bypass. Arch Surg 1983;118:681-4.
61. Kjellin, A., Ramel, S., Rossner, S., et al. Gastroesophageal Reflux in Obese Patients Is Not Reduced by Weight Reduction. Scand. J Gastroenterol. 1996;31:1047-51.
62. Jones, K. B., Jr., Allen, T. V., Manas, K. J., et al. Roux-Y Gastric Bypass: an Effective Anti-Reflux Procedure. Obes. Surg 1991;:295-8.
63. Smith, S. C., Edwards, C. B., Goodman, G. N. Symptomatic and Clinical Improvement in Morbidly Obese Patients With Gastroesophageal Reflux Disease Following Roux-En-Y Gastric Bypass. Obes. Surg 1997;7:479-84.
64. Dixon, J.B., Bhathal, P.S., Hughes, N.R., et al. Nonalcoholic Fatty Liver Disease: Improvement in Liver Histological Analysis With Weight Loss. Hepatology. 2004;39:1637-54.
65. Solga, S.F., Alkhuraishe, A., Clark, J.M. Gartic bypass surgery markedly improves liver histology in patients with nonalcoholic steatohepatitis. Gastroenterology 124, 239, 2003.
66. Christo, N.V., Sampalis, J.S., Liberman, M. et al. Surgery Decreases Long Term Mortality, Morbidity and Health Care Use in Morbidly Obese Patients. Ann Surg 2004;240:416-24.
67. Livingston, E. H. Obesity and Its Surgical Management. Am J Surg 2002;184:103-13.
68. Steinbrook, R. Surgery for Severe Obesity. N. Engl. J Med. 3-11-2004;350(11):1075-9.
69. NIH Conference. Gastrointestinal Surgery for Severe Obesity. Consensus Development Conference Panel. Ann. Intern. Med. 12-15-1991;115:956-61.
70. USA Today Health and Behaviour 11/8/2004. USA Today. 2004.Available: http://www.usatoday.com/news/health/2004-11-08-medicare-usat_x.htm